Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Recent & Breaking News (NDAQ:DXR)

Daxor Awarded $1.1 Million Contract from United States Department of Defense (DOD) for Rapid Portable Blood Volume Analyzer

GlobeNewswire April 23, 2020

Daxor Corporation's BVA-100® Test Used to Guide Treatment In COVID-19 Patient

GlobeNewswire March 20, 2020

Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs

GlobeNewswire March 9, 2020

Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire March 6, 2020

Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire March 3, 2020

Daxor Corporation Announces Engagement with Hospitals and Government for Use of the Blood Volume Analyzer (BVA-100®) to Stem COVID-19 Deaths

GlobeNewswire March 2, 2020

DAXOR CORPORATION ANNOUNCES RISE IN KIT SALES AND FILES FORM N-CSR FOR 2019

GlobeNewswire March 2, 2020

New Research Further Demonstrates Clinical Superiority of Daxor Corporation's Blood Volume Analyzer (BVA-100®) in Critical Care

GlobeNewswire February 20, 2020

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 49th Congress

GlobeNewswire February 12, 2020

Novel Study from Yale University Utilizes Daxor's Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin

GlobeNewswire November 21, 2019

Daxor Corporation to Exhibit at American Heart Association's Scientific Sessions 2019

GlobeNewswire November 12, 2019

Daxor to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 1:30 PM Central Time

GlobeNewswire October 10, 2019

Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension

GlobeNewswire September 24, 2019

New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor's Diagnostic Technology

GlobeNewswire September 18, 2019

Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America

GlobeNewswire September 11, 2019

Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019

GlobeNewswire September 4, 2019

Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest

GlobeNewswire August 6, 2019

Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test

GlobeNewswire June 18, 2019

Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019

GlobeNewswire May 31, 2019

Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice

GlobeNewswire May 30, 2019